Adenosine and guanosine are naturally-occurring and structurally similar purines. Moreover, naturally- occurring cyclic analogues of adenosine and guanosine are involved in similar physiological processes (e.g., both cAMP and cGMP mediate vasodilation). Strangely, at first blush it would seem that evolution broke the symmetry between adenosine and guanosine by bestowing cells with adenosine, but not guanosine, receptors. Thus the standard view is that adenosine serves as a physiological regulator of cellular function via activation of its own cell-surface receptors, while guanosine is merely an idle bystander. The purpose of this application is to challenge this received view by proposing that guanosine also plays an important role in cellular physiology, not via its own receptors but rather by engaging a powerful collaborative mechanism involving adenosine. In this regard, we hypothesize that extracellular guanosine is THE major physiological determinant of extracellular levels of adenosine because guanosine blocks the disposition of adenosine from the extracellular compartment allowing greater activation of adenosine cell-surface receptors due to increased extracellular adenosine levels. We refer to this guanosine-adenosine interaction as the GUANOSINE- ADENOSINE MECHANISM. Our pilot experiments strongly suggest that our hypothesis is correct. In preglomerular vascular smooth muscle cells (a model system for microvascular smooth muscle cells) we observe that for any given amount of adenosine added to cells, the extracellular concentrations of adenosine [as measured by high performance liquid chromatography-mass spectrometry (LC-MS/MS)] are more than 10- fold higher when guanosine is also added to the cells. We also find that cellular stress/injury increases extracellular levels of BOTH guanosine and adenosine. Moreover, we find that guanosine PROFOUNDLY augments the biological effects of adenosine in vivo! These findings suggest that extracellular guanosine, by blocking the disposition of extracellular adenosine, is the most important physiological determinant of extracellular levels of adenosine yet discovered. We propose to test the existence of, the mechanism of and the importance of the Guanosine-Adenosine Mechanism with the following six Specific Aims:
Aim 1 - To determine the existence of the Guanosine-Adenosine Mechanism in vascular and renal cell types;
Aim 2 - To determine whether the Guanosine-Adenosine Mechanism is mediated directly by guanosine or indirectly by conversion of guanosine to guanine;
Aim 3 - To determine whether the Guanosine-Adenosine Mechanism involves inhibition by guanosine of enzymes involved in adenosine metabolism;
Aim 4 - To determine whether the Guanosine-Adenosine Mechanism involves inhibition by guanosine of transporters involved in adenosine uptake;
Aim 5 - To determine whether the Guanosine-Adenosine Mechanism importantly contributes to elevated extracellular levels of adenosine following cellular stress with energy depletion;
and Aim 6 - To determine whether the Guanosine-Adenosine Mechanism amplifies the effects of adenosine in vivo.

Public Health Relevance

Adenosine is a critical """"""""retaliatory"""""""" metabolite. During cellular/tissue stress and injury, extracellular adenosine levels are elevated and activate cell surface receptors that mediate tissue/cellular protection (or in some cases participate in adverse responses). Our pilot experiments show that cellular stress/injury increases extracellular levels of guanosine as much as or more than extracellular levels of adenosine and that extracellular guanosine elevates the levels of extracellular adenosine by interfering with the disposition of adenosine from the extracellular compartment. Manipulation of this mechanism, which we call this the """"""""Guanosine-Adenosine Mechanism,"""""""" can be exploited to treat diseases of the kidneys, heart, blood vessels, lungs, brain and immune system.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL109002-01A1
Application #
8369704
Study Section
Hypertension and Microcirculation Study Section (HM)
Program Officer
OH, Youngsuk
Project Start
2012-07-01
Project End
2016-05-31
Budget Start
2012-07-01
Budget End
2013-05-31
Support Year
1
Fiscal Year
2012
Total Cost
$381,250
Indirect Cost
$131,250
Name
University of Pittsburgh
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Ziebart, Andreas; Huber, Ulrich; Jeske, Sandra et al. (2018) The influence of chemotherapy on adenosine-producing B cells in patients with head and neck squamous cell carcinoma. Oncotarget 9:5834-5847
Theodoraki, M-N; Hoffmann, T K; Jackson, E K et al. (2018) Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence. Clin Exp Immunol 194:67-78
Jackson, Travis C; Kotermanski, Shawn E; Kochanek, Patrick M et al. (2018) Oxidative Stress Induces Release of 2'-AMP from Microglia. Brain Res :
Jackson, Edwin K; Mi, Eric; Ritov, Vladimir B et al. (2018) Extracellular Ubiquitin(1-76) and Ubiquitin(1-74) Regulate Cardiac Fibroblast Proliferation. Hypertension 72:909-917
Jackson, Edwin K; Gillespie, Delbert G; Mi, Zaichuan et al. (2018) Adenosine Receptors Influence Hypertension in Dahl Salt-Sensitive Rats: Dependence on Receptor Subtype, Salt Diet, and Sex. Hypertension 72:511-521
Jackson, Edwin K; Zhang, Yumeng; Cheng, Dongmei (2017) Alkaline Phosphatase Inhibitors Attenuate Renovascular Responses to Norepinephrine. Hypertension 69:484-493
Hong, Chang-Sook; Sharma, Priyanka; Yerneni, Saigopalakrishna S et al. (2017) Circulating exosomes carrying an immunosuppressive cargo interfere with cellular immunotherapy in acute myeloid leukemia. Sci Rep 7:14684
Jackson, Edwin K; Mi, Zaichuan (2017) 8-Aminoguanosine Exerts Diuretic, Natriuretic, and Glucosuric Activity via Conversion to 8-Aminoguanine, Yet Has Direct Antikaliuretic Effects. J Pharmacol Exp Ther 363:358-366
Jackson, Edwin K; Kotermanski, Shawn E; Menshikova, Elizabeth V et al. (2017) Adenosine production by brain cells. J Neurochem 141:676-693
Schaufelberger, Sara A; Rosselli, Marinella; Barchiesi, Federica et al. (2016) 2-Methoxyestradiol, an endogenous 17?-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism. Am J Physiol Endocrinol Metab 310:E313-22

Showing the most recent 10 out of 37 publications